When you compare the $7 billion price tag for AMLN with the money MNKD needs to get Afrezza to the finish line and into production ($300 million more?) I don't see why MNKD cannot negotiate a partnership/marketing agreement which funds this phase and locks in the partnership agreement. I have to believe that there are willing partners and that even the dollar amount is not the stumbling block. Rather Al is just trying to negotiate too tough a deal in terms of control of the product and how the money is split. And maybe after Boston Scientific he has gotten a bad reputation as a partner.